Trials / Completed
CompletedNCT02777216
ConfidenHT System for Diagnostic Electrical Mapping of Renal Nerves
ConfidenHTTM System Safety and Performance of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- BlueWind Medical · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and performance of the ConfidenHT System
Detailed description
To evaluate the safety and performance of the ConfidenHT System for diagnostic mapping of renal nerves; functional distribution of renal nerves and the effect of renal nerve stimulation on the blood pressure
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ConfidenHT system | ConfidenHT Medical system |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-11-01
- Completion
- 2017-12-01
- First posted
- 2016-05-19
- Last updated
- 2018-02-26
Locations
3 sites across 2 countries: Greece, Netherlands
Source: ClinicalTrials.gov record NCT02777216. Inclusion in this directory is not an endorsement.